Xiangzhong Zhao

Dr. Xiangzhong Zhao

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2012 in Marine Drugs
Verified
Journal Article
Open access
PDF file
MLMing Liu
Ming Liu
XZXiangzhong Zhao
Xiangzhong Zhao
JZJin Zhao
Jin Zhao
LXLin Xiao
Lin Xiao
HLHaizhou Liu
Haizhou Liu
XLXiukun Lin
Xiukun Lin
Mere15 is a novel polypeptide from Meretrix meretrix Linnaeus with cytotoxicity in solid cancer cells. In this study, we investigated its activity on human K562 chronic myelogenous leukemia cells. Mere15 inhibited the growth of K562 cells with IC50 values of 38.2 μg/mL. Mere15 also caused concentration dependent induction of apoptosis, with overproduction of reactive oxygen species and loss of mitochondrial membrane potential. Moreover, Mere15 arrested cell cycle progression at G0/G1 phase of K562 cells in a concentration dependent manner. In addition, Mere15 caused the disassembly of the microtubule cytoskeleton in K562 cells and inhibited the polymerization of tubulin in a cell free system via interaction with tubulin. We concluded that Mere15 was cytotoxic to K562 leukemia cells and the cytotoxicity was related to the apoptosis induction, cell cycle arrest and microtubule disassembly. These results implied that Merer15 was a broad spectrum anticancer polypeptide, not only cytotoxic to various solid cancer cells but also to the chronic myelogenous leukemia cells. Mere15 may have therapeutic potential for the treatment of leukemia.

10 February 2018 in FEBS Open Bio
Verified
Journal Article
Open access
PDF file
LSLeping Shao
Leping Shao
LCLi Cui
Li Cui
JLJingru Lu
Jingru Lu
YLYanhua Lang
Yanhua Lang
Irene BottilloIrene Bottillo
Irene Bottillo
XZXiangzhong Zhao
Xiangzhong Zhao
Pseudohypoaldosteronism type II (PHAII) is a rare renal tubular disease that is inherited in an autosomal dominant manner. Mutations in four genes (WNK1, WNK4, CUL3, and KLHL3) have been identified to be responsible for this disease. Cullin 3 (CUL3) and KLHL3 are subunits of Cullin–RING E3 ubiquitin ligase complexes, and the serine–threonine kinases WNK1 and WNK4 are substrates of this ubiquitin ligase. For CUL3, all mutations associated with PHAII exclusively lead to exon 9 skipping. In this study, we identified a Chinese PHAII kindred caused by a novel synonymous mutation (c.1221A > G p.Glu407Glu) in CUL3, and explored its effects on exon 9 abnormal splicing through an in vitro splicing assay and study of the patients’ RNA. We obtained evidence that this synonymous mutation leads to complete exon 9 skipping, and in silico bioinformatics analysis demonstrated that the CUL3 c.1221A > G mutation might decrease the ratio of exonic splicing enhancers and silencers. This is the first report of PHAII in Chinese patients with a novel CUL3 mutation. Our findings add a novel pathogenic splicing variant to the CUL3 mutational spectrum and provide reference for further research on mechanisms of splicing modulation and development of potential therapeutic reagents for PHAII.

20 September 2016 in Scientific Reports
Verified
Journal Article
Open access
CWCui Wang
Cui Wang
JLJingru Lu
Jingru Lu
YLYanhua Lang
Yanhua Lang
TLTing Liu
Ting Liu
XWXiaoling Wang
Xiaoling Wang
LSLeping Shao
Leping Shao
Primary hyperoxaluria type 1 (PH1) is a rare genetic disease characterized by excessive oxalate accumulation in plasma and urine, resulting in various phenotypes because of allelic and clinical heterogeneity. This study aimed to detect disease-associated genetic mutations in three PH1 patients in a Chinese family. All AGXT exons and 3 common polymorphisms which might synergistically interact with mutations, including P11L, I340 M and IVSI+74 bp were analyzed by direct sequencing in all family members. It demonstrated that in each of three patients, a previously reported nonsense mutation p.R333* was in cis with a novel missense mutation p.M49L in the minor allele characterized by the polymorphism of 74-bp duplication in intron 1, while the other novel missense mutation p.N72I was in trans with both p.R333* and P.M49L in the major allele. Kidney stones from two sibling patients were also observed though stereomicroscopic examination and scanning electron microscopy. Distinct morphological and inner-structure differences in calculi were noticed, suggesting clinical heterozygosity of PH1 to a certain extent. In brief, two novel missense mutations were identified probably in association with PH1, a finding which should provide an accurate tool for prenatal diagnosis, genetic counseling and screening for potential presymptomatic individuals.

23 June 2021 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
WGWencong Guo
Wencong Guo
QSQijing Song
Qijing Song
RZRuixiao Zhang
Ruixiao Zhang
QXQing Xin
Qing Xin
ZLZhiying Liu
Zhiying Liu
LSLeping Shao
Leping Shao

13 August 2021 in Nephrology
Verified
Journal Article
Closed access
PDF file
ZLZhiying Liu
Zhiying Liu
HZHaiyan Zhang
Haiyan Zhang
SZShipeng Zhao
Shipeng Zhao
QZQian Zhang
Qian Zhang
RZRuixiao Zhang
Ruixiao Zhang
XZXiangzhong Zhao
Xiangzhong Zhao

9 October 2025 in SLEEP
Verified
Journal Article
Closed access
BXBaiqiang Xue
Baiqiang Xue
MNMingming Niu
Mingming Niu
YSYuanchao Sun
Yuanchao Sun
LWLin Wang
Lin Wang
CWChuanhong Wu
Chuanhong Wu
ZLZhiqiang Li
Zhiqiang Li
Study Objectives: Insomnia and psychiatric disorders are frequently comorbid and heritable, yet their shared genetic architecture and neurobiological mechanisms remain poorly understood. We investigated the genetic overlap, biological pathways, and brain cell types linking insomnia with 12 psychiatric disorders. Methods: We analyzed genome-wide association study data from insomnia (Neff = 314,149) and 12 psychiatric disorders (Neff = 12,783–449,855). Genetic architecture was assessed using bivariate MiXeR. Shared loci were identified through conjunctional false discovery rate (conjFDR) and Association analysis based on SubSETs (ASSET). Gene-set enrichment was performed with MAGMA, and cell-type specificity was determined using SEISMIC analysis of single-cell RNA sequencing data from 36 brain cell types. Results: Significant genetic correlations emerged between insomnia and seven psychiatric disorders: attention-deficit/hyperactivity disorder (ADHD), anorexia nervosa (AN), anxiety disorders (ANX), autism spectrum disorder (ASD), bipolar disorder (BD), major depressive disorder (MDD), and schizophrenia (SCZ). Cross-trait analyses identified 70 shared genomic loci containing 97 candidate single nucleotide polymorphisms (SNPs), including novel associations: 7 with ADHD, 6 with AN, 3 with ANX, 3 with ASD, 5 with BD, 15 with MDD, and 19 with SCZ. Pathway enrichment analysis revealed GABAergic synapse signaling as a central mechanism. Cell-type analysis implicated eight cortical neuron subtypes—four GABAergic interneurons and four glutamatergic neurons. Of 71 genes mapped to shared loci, 33 showed significant expression in these neuronal populations. Conclusions: Our findings reveal extensive shared genetic architecture between insomnia and psychiatric disorders, converging on cortical GABA-glutamate circuitry dysfunction. These results identify potential therapeutic targets for comorbid conditions and demonstrate how integrating genetic epidemiology with cellular neuroscience can elucidate transdiagnostic mechanisms underlying neuropsychiatric comorbidity, informing precision medicine approaches.